Postoperative stroke in a child with cerebral palsy heterozygous for factor V Leiden.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 10864060)

Published in J Pediatr Hematol Oncol on July 20, 2000

Authors

M Steiner1, M Z Hodes, M Shreve, S Sundberg, J R Edson

Author Affiliations

1: Department of Pediatrics, Fairview-University Medical Center, Minneapolis, University of Minnesota, 55455, USA.

Articles by these authors

(truncated to the top 100)

Proceedings: A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh (1975) 2.10

Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood (1983) 1.98

Vibration frequencies and amplitudes in the aetiology of traumatic vasospastic disease. Lancet (1973) 1.92

Hemophiliacs with HIV antibody are actively infected. JAMA (1988) 1.55

Absence of HIV-1 infection in antibody-negative sexual partners of HIV-1 infected hemophiliacs. Transfusion (1989) 1.36

Defibrination syndrome in an infant born after abruptio placentae. J Pediatr (1968) 1.28

Studies of platelets in a variant of the Hermansky-Pudlak syndrome. Am J Pathol (1971) 1.13

Successful management of a subdural hematoma in a hemophiliac with an anti-factor VIII antibody. Blood (1973) 1.10

Plasminogen and antithrombin III deficiencies in the childhood nephrotic syndrome associated with plasminogenuria and antithrombinuria. J Pediatr (1980) 1.07

Cystic fibrosis presenting with severe hemorrhage due to vitamin K malabsorption: a report of three cases. Pediatrics (1970) 1.04

Acute effects and long-term variations in skin blood flow measured with laser Doppler flowmetry. Scand J Clin Lab Invest (1984) 1.02

Fibrinolytic treatment of the haemolytic-uraemic syndrome. Lancet (1972) 0.97

Prevalence of cytomegalovirus antibody in hemophiliacs and homosexuals infected with human immunodeficiency virus type 1. Transfusion (1988) 0.95

Kaolin partial thromboplastin time: high levels of procoagulants producing short clotting times or masking deficiencies of other procoagulants or low concentrations of anticoagulants. J Lab Clin Med (1967) 0.94

Aerobic endurance exercise or circuit-type resistance training for individuals with impaired glucose tolerance? Horm Metab Res (1998) 0.92

Enrichment for CFU-C from murine and human bone marrow using soybean agglutinin. Blood (1982) 0.92

The enigma of severe factor XI deficiency without hemmorrhagic symptoms. Distinction from Hageman factor and "Fletcher factor" deficiency; family study; and problems of diagnosis. Thromb Diath Haemorrh (1967) 0.92

Haemodynamic dose-efficacy of levosimendan in healthy volunteers. Eur J Clin Pharmacol (1994) 0.91

Subattomole-Sensitivity Microchip Nanoelectrospray Source with Time-of-Flight Mass Spectrometry Detection. Anal Chem (1999) 0.90

Effect of hydroxyethyl starch and dextran on plasma volume and blood hemostasis and coagulation. J Clin Pharmacol (1984) 0.90

Impairment of captopril bioavailability by concomitant food and antacid intake. Int J Clin Pharmacol Ther Toxicol (1984) 0.88

Rapid plasma exchange with the continuous flow centrifuge. Transfusion (1973) 0.88

Nitroglycerin ointment effective for seven hours in severe angina pectoris. Acta Med Scand (1983) 0.88

Coagulation in cyanotic congenital heart disease. Am J Dis Child (1972) 0.88

The effect of prolonged doxycycline therapy on Chlamydia pneumoniae serological markers, coronary heart disease risk factors and forearm basal nitric oxide production. J Antimicrob Chemother (1998) 0.87

The effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia. J Pediatr (1982) 0.86

Allogeneic hemopoietic stem cell transplantation using mouse spleen cells fractionated by lectins: in vitro study of cell fractions. Proc Natl Acad Sci U S A (1980) 0.86

Low platelet adhesiveness and other hemostatic abnormalities in hypothyroidism. Ann Intern Med (1975) 0.85

Electrophysiologic effects of a calcium sensitizer inotrope levosimendan administered intravenously in patients with normal cardiac function. J Cardiovasc Pharmacol (2000) 0.85

Chronic autoimmune thrombocytopenic purpura associated with haemophilia A. Postgrad Med J (1982) 0.84

Dose-range study of a new calcium sensitizer, levosimendan, in patients with left ventricular dysfunction. J Cardiovasc Pharmacol (1995) 0.84

Pulmonary cytolytic thrombi: a newly recognized complication of stem cell transplantation. Bone Marrow Transplant (2000) 0.84

An insertion within the factor IX gene: hemophilia BEl Salvador. Am J Hum Genet (1988) 0.83

Thrombotic and hemorrhagic strokes complicating early therapy for childhood acute lymphoblastic leukemia. Cancer (1980) 0.83

Maximal oxygen uptake in relation to age in blind and normal boys and girls. Acta Paediatr Scand (1982) 0.82

The effect of L-asparaginase of plasma coagulation factors in acute lymphoblastic leukemia. Cancer (1977) 0.82

Acute promyelocytic leukemia. Management of the coagulopathy during daunorubicin-prednisone remission induction. Arch Intern Med (1978) 0.81

Abnormalities of platelet function in the myeloproliferative disorders. JAMA (1972) 0.81

Sagittal sinus thrombosis in the nephrotic syndrome. J Pediatr (1980) 0.81

The Obstructive Lung Disease in Northern Sweden (OLIN) longitudinal paediatric study I--the first 10 years. Clin Respir J (2008) 0.80

Factor V deficiency in Philadelphia-positive chronic myelogenous leukemia. Blood (1980) 0.80

Retinal surgery complicated by a spontaneously acquired factor VIII inhibitor. Am J Ophthalmol (1978) 0.79

Effects of flunarizine and pentoxifylline on walking distance and blood rheology in claudication. Angiology (1984) 0.79

UV mutagenesis in E. coli with excision repair initiated by uvrABC or denV gene products. Mutat Res (1988) 0.79

Comparison of blood pressure response to heat stress in sauna in young hypertensive patients treated with atenolol and diltiazem. Am J Cardiol (1989) 0.79

Serial coagulation studies in patients undergoing Mustard procedure. Ann Thorac Surg (1973) 0.79

Influence of heart rate on systolic time intervals. Am J Cardiol (1986) 0.78

Heparin-induced thrombocytopenia. J Lab Clin Med (1992) 0.78

COMT inhibition by entacapone does not affect growth hormone or prolactin secretion in healthy volunteers. J Neural Transm (Vienna) (1996) 0.78

Spontaneously acquired factor IX inhibitor in a nonhemophiliac child. J Pediatr (1978) 0.78

Drug- and temperature-induced changes in peripheral circulation measured by laser-Doppler flowmetry and digital-pulse plethysmography. Scand J Clin Lab Invest (1986) 0.78

Characterization of phosphohydrolase activity in bovine spleen extracts: identification of a bis(p-nitrophenyl)phosphate-hydrolyzing activity (phosphodiesterase IV) which also acts on adenosine triphosphate. Anal Biochem (1985) 0.78

Efficacy of conventional and sustained-release verapamil in stable angina pectoris. Ann Med (1992) 0.78

The effect of entacapone on the disposition and hemodynamic effects of intravenous isoproterenol and epinephrine. Clin Pharmacol Ther (1995) 0.77

A five-year follow-up study on cardiorespiratory function in adolescent elite endurance runners. Acta Paediatr Scand (1983) 0.77

The effects of soaking and lotion on dryness of the skin in the feet of the elderly patient. J Am Podiatry Assoc (1974) 0.77

Effects of captopril on blood pressure and respiratory function compared to verapamil in patients with hypertension and asthma. J Cardiovasc Pharmacol (1990) 0.76

Simultaneous inhibition of catecholamine-O-methylation by entacapone and neuronal uptake by imipramine: lack of interactions. Eur J Clin Pharmacol (1996) 0.76

Separation of linoleic acid oxidation products by micellar electrokinetic capillary chromatography and nonaqueous capillary electrophoresis. Electrophoresis (1999) 0.76

Management of common pediatric fractures. Pediatr Clin North Am (1996) 0.76

Recurrent venous thrombosis associated with inherited deficiency of heparin cofactor II. Br J Haematol (1991) 0.76

Pharmacokinetic-pharmacodynamic interrelationships of intravenous and oral levosimendan in patients with severe congestive heart failure. Int J Clin Pharmacol Ther (2003) 0.76

Influence of beta blockade and intrinsic sympathomimetic activity on hemodynamics, inotropy and respiration at rest and during exercise. Am J Cardiol (1986) 0.76

Effect of low dose diuretics on plasma and blood cell electrolytes, plasma uric acid and blood glucose. Acta Med Scand Suppl (1982) 0.76

Proceedings: Differences in platelet storage pool deficiency (SPD) of Hermansky Pudlak syndrome (HPS) and non-albinos (NA). Thromb Diath Haemorrh (1975) 0.76

The hemodynamic and pharmacokinetic interactions between chronic use of oral levosimendan and digoxin in patients with NYHA Classes II-III heart failure. Int J Clin Pharmacol Ther (2008) 0.75

Astemizole in the treatment of hay fever. Allergy (1983) 0.75

The circadian heart rate but not blood pressure profile is influenced by the timing of beta-blocker administration in hypertensives. Eur J Clin Pharmacol (1991) 0.75

Simultaneous inhibition of catechol-O-methyltransferase and monoamine oxidase A: effects on hemodynamics and catecholamine metabolism in healthy volunteers. Clin Pharmacol Ther (1996) 0.75

An alternative method for calculating changes in arterial calf blood flow at rest. An initial study. Eur J Appl Physiol Occup Physiol (1986) 0.75

Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction. Ann Clin Res (1984) 0.75

Exercise capacity and hemodynamics in persons aged 20 to 50 years with systemic hypertension treated with diltiazem and atenolol. Am J Cardiol (1987) 0.75

Lung volume and exercise ventilation in blind and normal boys and girls. Respiration (1983) 0.75

The effects of physical training and flunarizine on walking capacity in intermittent claudication. Scand J Rehabil Med (1984) 0.75

Comparison of potassium alone and potassium-magnesium supplementation in patients with heart failure using hydrochlorothiazide. Magnesium (1989) 0.75

Comparison of ketanserin and pindolol in hypertension. J Hypertens Suppl (1986) 0.75

[Status following fracture of the mandibular condyle]. Sven Tandlak Tidskr (1966) 0.75

Suitability of plasma expanders in patients receiving low-dose heparin for prevention of venous thrombosis after surgery. Acta Anaesthesiol Scand (1983) 0.75

Antigenic differences in functionally normal antihemophiliac globulin in different bovine strains. J Lab Clin Med (1974) 0.75

Antigenic differences among bovine and porcine Factor VIII concentrates. Am J Clin Pathol (1976) 0.75

Sustained release verapamil in hypertension. Results from a noninvasive ambulatory blood pressure monitoring and a clinical study. Eur J Clin Pharmacol (1986) 0.75

[Continuous indirect measurement of blood pressure]. Duodecim (1988) 0.75

Hemodynamic effects of the novel cardiotonic drug simendan: echocardiographic assessment in healthy volunteers. Cardiovasc Drugs Ther (1994) 0.75

Detection of factor VIII and IX inhibitors after first exposure to heat-treated concentrates. Lancet (1987) 0.75

Mechanisms and dynamics of intravascular coagulation. Geriatrics (1974) 0.75

[A case of advanced perimyolysis]. Sven Tandlak Tidskr (1966) 0.75

Tympanostomy tubes in children with hemophilia A. Laryngoscope (1984) 0.75

Intravascular coagulation. Minn Med (1979) 0.75

A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor. Am J Clin Pathol (1986) 0.75

Pharmacokinetics of slow-release diltiazem and its effect on atrioventricular conduction in healthy volunteers. Eur J Clin Pharmacol (1986) 0.75

Treatment of a spontaneous intracerebral hematoma with exchange transfusions in an infant with hemophilia B. J Pediatr (1984) 0.75

North American study of factor VIII concentrate potency. Scand J Haematol Suppl (1984) 0.75

Abnormal prothrombin crossed-immunoelectrophoresis in patients with lupus inhibitors. Blood (1984) 0.75

Resting- and postexercise-ECG findings in an adult Lapp population. Ann Clin Res (1983) 0.75

COMT inhibition by high-dose entacapone does not affect hemodynamics but changes catecholamine metabolism in healthy volunteers at rest and during exercise. Int J Clin Pharmacol Ther (1994) 0.75

Noninvasive, automatic 24-h ambulatory blood pressure monitoring in normotensive subjects. Eur J Appl Physiol Occup Physiol (1987) 0.75

Kallikrein inhibition and C1-esterase inhibitor levels in patients with the lupus inhibitor. Am J Clin Pathol (1987) 0.75

Heparin cofactor II assay. Elimination of heparin and antithrombin-III effects. Am J Clin Pathol (1988) 0.75

Cardiorespiratory function in competitive endurance runners aged 12-16 years compared with ordinary boys. Acta Paediatr Scand (1982) 0.75

Interpreting partial thromboplastin times. Minn Med (1975) 0.75